| Previous Close | 0.4280 |
| Open | 0.4000 |
| Bid | 0.4000 x 0 |
| Ask | 0.4280 x 0 |
| Day's Range | 0.4000 - 0.4000 |
| 52 Week Range | 0.1590 - 0.7150 |
| Volume | 6,000 |
| Avg. Volume | 281 |
| Market Cap | 13.01M |
| Beta (5Y Monthly) | 1.39 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0870 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNW GroupCanntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement
TORONTO, June 2, 2020 /CNW/ -Â Canntab Therapeutics Limited (CSE:PILL.CN - News)(OTCQB:CTABF - News) (FRA:TBF1.F - News) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it is today beginning production of its instant release tablets and has already entered into its first purchase agreement with MediPharm Labs ("MediPharm") (TSX:LABS.TO - News)(OTCQX:MEDIF - News)(Deutsche Borse: MLZ), a global leader in pharma quality cannabinoid based products. Orders under the agreement will be composed of a mix of Canntab's proprietary instant release tablets delivering THC, CBD and a combination of THC/CBD in 12 different strengths. MediPharm will purchase and distribute cannabis products on a non-exclusive basis across Canada, through licensed provincial dispensaries.
CNW GroupCanntab Appoints Joshi Laxminarayan as Chief Scientific Officer
TORONTO, May 15, 2020 /CNW/ - Canntab Therapeutics Limited (CSE:PILL.CN - News)(OTCQB:CTABF - News) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the appointment of Joshi Laxminarayan as Chief Scientific Officer (CSO). In his role as CSO, Mr. Laxminarayan will be responsible for directing Canntab's strategic research and partnership program, and overseeing the Company's ongoing manufacturing and distribution operations.
CNW GroupCanntab to Present at the Canaccord Genuity 2020 Virtual Cannabis Conference
TORONTO , May 11, 2020 /CNW/ - Canntab Therapeutics Limited ( CSE:PILL.CN )( OTCQB:CTABF ) ( FRA:TBF1.F ) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene ...
